|Bid||0.00 x 1100|
|Ask||0.00 x 1100|
|Day's range||240.95 - 247.61|
|52-week range||197.75 - 284.97|
|Beta (5Y monthly)||0.77|
|PE ratio (TTM)||46.89|
|Earnings date||05 May 2021 - 10 May 2021|
|Forward dividend & yield||3.32 (1.35%)|
|Ex-dividend date||09 Mar 2021|
|1y target est||281.57|
Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, Inc. ("GSL"), a privately-held company that develops smart medication devices for the storage and tracking of controlled substances and patient specific medications that improve the security, efficiency and compliance of medication storage, as well as analytic capabilities to further improve inventory management, including of controlled substances, regulatory compliance and patient safety.
The new president has a lot of work to do, and many companies are likely to benefit from some of his priorities.